Determine if Human Infant Weight Gain Can be Modulated to Prevent Obesity
Primary Purpose
Obesity, Infant
Status
Not yet recruiting
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Calibration of infant breast milk and formula milk intake
Sponsored by
About this trial
This is an interventional prevention trial for Obesity, Infant focused on measuring obesity, hyperphagia, breast milk
Eligibility Criteria
Mother infant dyads are eligible for the study, with equal proportion of male and female infant in each study group.
Inclusion Criteria:
- Breast Milk Calibration Study: Study women (pre-pregnant BMI>30) who are providing exclusive human milk via pumping and bottle (50%/50% male/female) will be recruited at the 7-9 week postpartum visit.
- Formula Milk Calibration Study: Study women (pre-pregnant BMI>30) who are providing formula via bottle (50%/50% male/female) will be recruited at the 7-9 week postpartum visit.
Exclusion Criteria:
- Breast Milk Calibration Study: breast implants, prior breast surgery, flat/ inverted nipples, tongue-tie or low birth weight infants.
- Formula Milk Calibration Study: low birth weight infants.
Sites / Locations
- Breastfeeding Center Ana Abrao, Federal of São Paulo University, Brazil
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Other
Arm Label
Standard Infant Feed Group
Calibrated Infant Feed Group
Arm Description
Infants will receive human milk or formula milk ad libitum.
Infants will have reduced human milk or formula milk intake.
Outcomes
Primary Outcome Measures
Infant normalized weight at 6 months of age
We will quantify effects of calibrated human milk or formula intake on the normalized weight of infants at 6 months of age.
Secondary Outcome Measures
Full Information
NCT ID
NCT04526860
First Posted
August 21, 2020
Last Updated
July 7, 2023
Sponsor
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Collaborators
Federal University of Sao Paulo
1. Study Identification
Unique Protocol Identification Number
NCT04526860
Brief Title
Determine if Human Infant Weight Gain Can be Modulated to Prevent Obesity
Official Title
Maternal Obesity Programs Offspring Hypothalamic Neurogenesis and Appetite: Mechanisms and Prevention of Hyperphagia-mediated Childhood Obesity
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
December 20, 2023 (Anticipated)
Primary Completion Date
December 1, 2024 (Anticipated)
Study Completion Date
December 1, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Collaborators
Federal University of Sao Paulo
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The global obesity epidemic has extended to low and middle income countries (LMICs) in which in a dramatic nutritional transition has shifted from maternal/child undernutrition to overnutrition. Within Brazil, maternal overweight/obesity (OW/OB) and childhood obesity have dramatically increased. During developmental periods, exposure to maternal OB and high-fat diet increases the risk of childhood and adult obesity, in part a result of increased food intake. Studies confirm that offspring of overweight and obese (OW/OB) women are at increased risk of newborn and age 1 year adiposity, and infant adiposity predicts childhood and adult obesity. The investigators hypothesize that that infants of OW/OB mothers have both relative increased appetite and are provided human milk with increased caloric composition. The investigators propose that calibrating milk or formula intake in infants of overweight mothers can reduce the incidence of infant obesity.
Detailed Description
This is a clinical intervention study to calibrate infant milk or formula intake and modulate infant weight gain to prevent the development of infant obesity. The studies will be performed at the Ana Abrão Breastfeeding Center, Federal University of São Paulo, Brazil.
Postpartum women will be with pre-pregnant BMI 30 who are providing exclusive human milk via pumping and bottle (n = 50; 50 percent male and 50 percent female) will be recruited at the 7-9 week postpartum visit, Study women will be randomly assigned (computer generated; blocks of 10) to a Standard Feed (SF) or Calibrated Feed (CF) groups. Both groups will be seen at 2 week intervals for assessment of infant weight, supine length, BMI and skinfold thickness. Continuation of exclusive human milk will be confirmed with questionnaires.
In the SF group, mothers will provide bottled human milk ad libitum. In the CF group, infant weight will be assessed in relation to the daily milk volume and approximate caloric intake (based upon maternal human milk sample analysis). Should infants be within 10th to 90th percentile of WHO BMI growth curves, no intervention will be made. Should the infant be greater than 90th percentile of WHO BMI, the provided human milk volume and daily calorie intake will be adjusted in relation to previously established normal volumes for newborn age, with the input of pediatric physician. In no case, will the daily milk volume or calorie intake be reduced by more than 10%. At the subsequent visit, adjustments in milk volume and calorie intake will continue, dependent upon the infant BMI trend, accommodating the normal increase in milk intake with advancing age. Should the infant be less than 10th percentile of WHO BMI, the maternal- infant dyad will be referred for a pediatric and nutrition consults to assess the cause and treatment for potential nutrient deficiency. At 26 wks, the investigators will assess the distribution of infant weight BMI between SF and CF groups.
An identical Study will be undertaken (Standard Feed and Calibrated Feed), with the exception that only current formula feed mothers will be enrolled. All women will be provided a standard brand of commercial formula feed, for which total caloric content and composition will be determined.
Data Analysis. The investigators will compare standard feed vs calibrated feed infant BMI curves with repeated measures ANOVA (time, BMI) with covariates of the group assignment. The investigators will compare infant weight and BMI curves by maternal BMI and infant birth weight, and between human milk and formula groups. The investigators will analyze growth curves of infants exceeding WHO standards which received adjustments in feedings to assess if early changes in growth curves or milk composition is predictive of weight changes, so as to determine the potential for interventions prior to 90th percentile.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Infant
Keywords
obesity, hyperphagia, breast milk
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Calibration of infant breast milk and formula intake: We will calibrate (reduce) the pumped breast milk or formula intake of infants of overweight and obese mothers who exceed 2 standard deviations of normal WHO weight standards, in order to prevent infant obesity and subsequent childhood obesity.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Standard Infant Feed Group
Arm Type
No Intervention
Arm Description
Infants will receive human milk or formula milk ad libitum.
Arm Title
Calibrated Infant Feed Group
Arm Type
Other
Arm Description
Infants will have reduced human milk or formula milk intake.
Intervention Type
Other
Intervention Name(s)
Calibration of infant breast milk and formula milk intake
Intervention Description
We will calibrate (reduce) the pumped breast milk or formula intake of infants of overweight and obese mothers who exceed 2 standard deviations of normal WHO weight standards, in order to prevent infant obesity and subsequent childhood obesity.
Primary Outcome Measure Information:
Title
Infant normalized weight at 6 months of age
Description
We will quantify effects of calibrated human milk or formula intake on the normalized weight of infants at 6 months of age.
Time Frame
6 months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Mother infant dyads are eligible for the study, with equal proportion of male and female infant in each study group.
Inclusion Criteria:
Breast Milk Calibration Study: Study women (pre-pregnant BMI>30) who are providing exclusive human milk via pumping and bottle (50%/50% male/female) will be recruited at the 7-9 week postpartum visit.
Formula Milk Calibration Study: Study women (pre-pregnant BMI>30) who are providing formula via bottle (50%/50% male/female) will be recruited at the 7-9 week postpartum visit.
Exclusion Criteria:
Breast Milk Calibration Study: breast implants, prior breast surgery, flat/ inverted nipples, tongue-tie or low birth weight infants.
Formula Milk Calibration Study: low birth weight infants.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kelly P Coca, RNM, PhD
Phone
+55 11 5576-4430
Ext
1625
Email
kcoca@unifesp.br
First Name & Middle Initial & Last Name or Official Title & Degree
Cristiana G Araújo, MS
Phone
+55 11 5576-4891
Email
c.guiller@huhsp.org.br
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael G Ross, MD
Organizational Affiliation
The Lundquist Institute
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Mina Desai, PhD
Organizational Affiliation
The Lundquist Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
Breastfeeding Center Ana Abrao, Federal of São Paulo University, Brazil
City
Sao Paulo
State/Province
San Paulo
ZIP/Postal Code
04025-002
Country
Brazil
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kelly Coca, CNM
Phone
+55 11 5576-4430
Ext
1625
Email
kcoca@unifesp.br
First Name & Middle Initial & Last Name & Degree
Cristiana Araujo, RN
Phone
+55 11 5576-4891
Email
c.guiller@huhsp.org.br
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Data will be shared at national and international meetings spanning obstetrics, pediatrics and public health. The findings of the study will be published according to NIH guideline for publication and accepted manuscripts will be deposited to Pub Med Central to ensure public access.
For the Brazilian community, we will disseminate research data through educational program, workshops and conferences organized by the Brazil Ministry of Health. It is important to note that we plan to translate our research findings first into Portuguese (language of Brazil) as well as Spanish which is the predominant language spoken in our neighboring countries surrounding Brazil.
IPD Sharing Time Frame
Data available at completion of protocol estimated Dec 2023
IPD Sharing Access Criteria
Established research organization
Citations:
PubMed Identifier
25411303
Citation
Conde WL, Monteiro CA. Nutrition transition and double burden of undernutrition and excess of weight in Brazil. Am J Clin Nutr. 2014 Dec;100(6):1617S-22S. doi: 10.3945/ajcn.114.084764. Epub 2014 Oct 29.
Results Reference
background
PubMed Identifier
18824817
Citation
Satpathy HK, Fleming A, Frey D, Barsoom M, Satpathy C, Khandalavala J. Maternal obesity and pregnancy. Postgrad Med. 2008 Sep 15;120(3):E01-9. doi: 10.3810/pgm.2008.09.1920.
Results Reference
background
PubMed Identifier
30421138
Citation
Kaul P, Bowker SL, Savu A, Yeung RO, Donovan LE, Ryan EA. Association between maternal diabetes, being large for gestational age and breast-feeding on being overweight or obese in childhood. Diabetologia. 2019 Feb;62(2):249-258. doi: 10.1007/s00125-018-4758-0. Epub 2018 Nov 13.
Results Reference
background
PubMed Identifier
19602635
Citation
Davenport MH, Cabrero MR. Maternal nutritional history predicts obesity in adult offspring independent of postnatal diet. J Physiol. 2009 Jul 15;587(Pt 14):3423-4. doi: 10.1113/jphysiol.2009.174896. No abstract available.
Results Reference
background
PubMed Identifier
12198014
Citation
Guo SS, Wu W, Chumlea WC, Roche AF. Predicting overweight and obesity in adulthood from body mass index values in childhood and adolescence. Am J Clin Nutr. 2002 Sep;76(3):653-8. doi: 10.1093/ajcn/76.3.653.
Results Reference
background
PubMed Identifier
12915626
Citation
Catalano PM. Obesity and pregnancy--the propagation of a viscous cycle? J Clin Endocrinol Metab. 2003 Aug;88(8):3505-6. doi: 10.1210/jc.2003-031046. No abstract available.
Results Reference
background
PubMed Identifier
26865238
Citation
Prentice P, Ong KK, Schoemaker MH, van Tol EA, Vervoort J, Hughes IA, Acerini CL, Dunger DB. Breast milk nutrient content and infancy growth. Acta Paediatr. 2016 Jun;105(6):641-7. doi: 10.1111/apa.13362. Epub 2016 Apr 6.
Results Reference
background
PubMed Identifier
30968129
Citation
Isganaitis E, Venditti S, Matthews TJ, Lerin C, Demerath EW, Fields DA. Maternal obesity and the human milk metabolome: associations with infant body composition and postnatal weight gain. Am J Clin Nutr. 2019 Jul 1;110(1):111-120. doi: 10.1093/ajcn/nqy334.
Results Reference
background
PubMed Identifier
30092608
Citation
Young BE, Levek C, Reynolds RM, Rudolph MC, MacLean P, Hernandez TL, Friedman JE, Krebs NF. Bioactive components in human milk are differentially associated with rates of lean and fat mass deposition in infants of mothers with normal vs. elevated BMI. Pediatr Obes. 2018 Oct;13(10):598-606. doi: 10.1111/ijpo.12394. Epub 2018 Aug 9.
Results Reference
background
PubMed Identifier
24729519
Citation
Brunner S, Schmid D, Zang K, Much D, Knoeferl B, Kratzsch J, Amann-Gassner U, Bader BL, Hauner H. Breast milk leptin and adiponectin in relation to infant body composition up to 2 years. Pediatr Obes. 2015 Feb;10(1):67-73. doi: 10.1111/j.2047-6310.2014.222.x. Epub 2014 Apr 14.
Results Reference
background
Learn more about this trial
Determine if Human Infant Weight Gain Can be Modulated to Prevent Obesity
We'll reach out to this number within 24 hrs